Protein Supplements in Association With Prehabilitation Program for Cancer Patients Before Surgery

Suppléments protéinés en Association d'un Programme de préhabilitation Avant la Prise en Charge Chirurgicale d'un Cancer

The aim of study is to analyse the feasibility of the use of nutritionnal complements after exercices before surgery for cancer.

Body composition, muscle function and muscle mass will be analyse too.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

A prospective study will be carried out including adult patients with neoplasia who should benefit in their therapeutic strategy from oncological surgery. About fifty patients will be recruited in the oncology / surgery department at the Saint-Luc University Clinics in Brussels. Patients will be assessed at the initial consultation and after the pre-habilitation period, ie the day before the operation.

Dietary monitoring will be carried out in parallel with a physical and respiratory preparation program (prehabilitation) and the intake of protein nutritional supplements in the form of powder to be diluted will be carried out after each exercise session.

Study Type

Interventional

Enrollment (Actual)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1200
        • Cliniques Universitaires Saint-luc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patient with operable cancer
  • patient inform consent
  • min 18 years old
  • french or english speaking

Exclusion Criteria:

  • neuromuscular pathology
  • cardiorespiratory or orthopedic pathology that prevents physical activity
  • cognitive or psychiatric disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nutritional complement

A prospective study will be carried out including adult patients with neoplasia who should benefit in their therapeutic strategy from oncological surgery. About fifty patients will be recruited in the oncology / surgery department at the Saint-Luc University Clinics in Brussels. Patients will be assessed at the initial consultation and after the pre-habilitation period, ie the day before the operation.

Dietary monitoring will be carried out in parallel with a physical and respiratory preparation program (prehabilitation) and the intake of protein nutritional supplements in the form of powder to be diluted will be carried out after each exercise session.

Patient receive protein supplement in liquid form after each exercice session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adhesion rate of the use of nutritionnel complements after exercices before surgery for cancer
Time Frame: 3 weeks
The feasibility of this outcome will be assess by the adhesion rate : (number of protein shots taken) / (number of protein shots prescribed). The adhesion will be validated if> 75% of the holds are respected.
3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition (lean and fat mass)
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
Evaluated by an impedancemetry balance : pourcentage of lean and fat mass
Once at the inclusion and once the day before surgery (3 weeks)
Muscle function
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
This variable will be studied by the 6-minutes walk test (meters)
Once at the inclusion and once the day before surgery (3 weeks)
Nutritional biological markers
Time Frame: Once at the inclusion
These variables will be studied by: prealbumin (g/L) and albumin (g/L) measures
Once at the inclusion
Antropometric markers - height
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
Height (meters)
Once at the inclusion and once the day before surgery (3 weeks)
Muscle strength
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
This variable will be studied by the hand grip test (kilograms)
Once at the inclusion and once the day before surgery (3 weeks)
Antropometric markers - weight
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
Weight (kilograms)
Once at the inclusion and once the day before surgery (3 weeks)
Antropometric markers - BMI
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
BMI (kg/m²) :weight and height will be combined to report BMI in kg/m²
Once at the inclusion and once the day before surgery (3 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yannick Deswysen, MD, Cliniques Universitaires Saint-luc

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 9, 2021

Primary Completion (Actual)

April 1, 2021

Study Completion (Actual)

April 30, 2022

Study Registration Dates

First Submitted

March 5, 2021

First Submitted That Met QC Criteria

March 22, 2021

First Posted (Actual)

March 24, 2021

Study Record Updates

Last Update Posted (Actual)

April 14, 2023

Last Update Submitted That Met QC Criteria

April 12, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2021/19JAN/022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Whey protein

Subscribe